| |
 |
|
Class Information
Number: 514/283
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Polycyclo ring system having the six-membered hetero ring as one of the cyclos > Pentacyclo ring system having the six-membered hetero ring as one of the cyclos > Ring nitrogen in the pentacyclo ring system is shared by five-membered cyclo and six-membered cyclo (e.g., vincamine, etc.)
Description: Subject matter wherein the ring nitrogen of the six-membered hetero ring is additionally a member of a five-membered cyclo in the pentacyclo ring system.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7612081 |
7-Polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groups |
Nov. 3, 2009 |
| 7601732 |
Crystalline form of 5(S)-(2-hydroxyethoxy)-20(S)-camptothecin |
Oct. 13, 2009 |
| 7601733 |
5(S)-(2'-hydroxyethoxy)-20(S)-camptothecin and its preparation and use for the treatment of cancer |
Oct. 13, 2009 |
| 7598279 |
Neurotherapeutic azole compounds |
Oct. 6, 2009 |
| 7595347 |
Method for protecting normal cells from cytotoxicity of chemotherapeutic agents |
Sep. 29, 2009 |
| 7589099 |
7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists |
Sep. 15, 2009 |
| 7572803 |
Hydrated crystalline esters of camptothecin |
Aug. 11, 2009 |
| 7557118 |
Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents |
Jul. 7, 2009 |
| 7521066 |
Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells |
Apr. 21, 2009 |
| 7517891 |
Camptothecin derivatives and improved synthetic methods |
Apr. 14, 2009 |
| 7498334 |
Pyrrolopyrimidines as phosphodiesterase VII inhibitors |
Mar. 3, 2009 |
| 7498340 |
Esters in position 20 of camptothecins |
Mar. 3, 2009 |
| 7485320 |
Liposome for incorporating large amounts of hydrophobic substances |
Feb. 3, 2009 |
| 7482359 |
Androgen receptor modulators |
Jan. 27, 2009 |
| 7462627 |
Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers |
Dec. 9, 2008 |
| 7455853 |
Medical devices containing rapamycin analogs |
Nov. 25, 2008 |
| 7452900 |
Esters in position 20 of camptothecins |
Nov. 18, 2008 |
| 7396837 |
Antitumoral analogs of lamellarins |
Jul. 8, 2008 |
| 7354918 |
Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol and applications thereof |
Apr. 8, 2008 |
| 7351714 |
7-imino derivatives of camptothecin having antitumor activity |
Apr. 1, 2008 |
| 7348025 |
Small particle liposome aerosols for delivery of anticancer drugs |
Mar. 25, 2008 |
| 7345046 |
Heteroaryl-fused pyrimidinyl compounds as anticancer agents |
Mar. 18, 2008 |
| 7332502 |
Phenanthroindolizidine alkaloids |
Feb. 19, 2008 |
| 7304037 |
Cytostatic conjugates with integrin ligands |
Dec. 4, 2007 |
| 7285533 |
Apo-2 ligand |
Oct. 23, 2007 |
| 7276252 |
Method and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form |
Oct. 2, 2007 |
| 7273873 |
Camptothecins with a modified lactone ring |
Sep. 25, 2007 |
| 7250422 |
Pharmaceutical composition containing berberine as effective ingredient for preventing and treating addiction or tolerance to morphine |
Jul. 31, 2007 |
| 7238704 |
Vinca derivatives |
Jul. 3, 2007 |
| RE39707 |
Camptothecin derivatives |
Jun. 26, 2007 |
| 7235564 |
Vinorelbine derivatives |
Jun. 26, 2007 |
| 7223770 |
Tocopherol-modified therapeutic drug compounds |
May. 29, 2007 |
| 7217770 |
Stable polymeric micelle-type drug composition and method for the preparation thereof |
May. 15, 2007 |
| 7205001 |
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
Apr. 17, 2007 |
| 7163930 |
Pharmaceutical compositions and methods relating to fucans |
Jan. 16, 2007 |
| 7163703 |
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
Jan. 16, 2007 |
| 7135481 |
Naphthalimide compositions and uses thereof |
Nov. 14, 2006 |
| 7122553 |
Liposomal formulation of irinotecan |
Oct. 17, 2006 |
| 7119124 |
Pharmaceutical compositions containing plasma protein |
Oct. 10, 2006 |
| 7105492 |
Camptothecin derivatives having antitumor activity |
Sep. 12, 2006 |
| 7091189 |
Medicament for treating lung cancer |
Aug. 15, 2006 |
| 7078411 |
Phospholipid transfer protein (PLTP) and cholestoral metabolism |
Jul. 18, 2006 |
| 7078209 |
CAK inhibitors and uses thereof |
Jul. 18, 2006 |
| 7071202 |
Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
Jul. 4, 2006 |
| 7071203 |
Pharmaceutically acceptable salts of 20(s)-camptothecins |
Jul. 4, 2006 |
| 7071204 |
Camptothecin analogs having an E-ring ketone |
Jul. 4, 2006 |
| 7053102 |
Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them |
May. 30, 2006 |
| 7049322 |
Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
May. 23, 2006 |
| 7044624 |
Vehicle light with movable reflector portion and shutter portion for selectively switching an illuminated area of light incident on a predetermined portion of the vehicle light during driving |
May. 16, 2006 |
| 7034024 |
Product inhibiting transduction of G heterotrimeric protein signals combined with another anti-cancer agent for therapeutic use in cancer treatment |
Apr. 25, 2006 |
|
|
|
